Literature DB >> 21829048

Alexithymia and tissue inflammation.

Kirsi Honkalampi1, Soili M Lehto, Heli Koivumaa-Honkanen, Jukka Hintikka, Leo Niskanen, Minna Valkonen-Korhonen, Heimo Viinamäki.   

Abstract

BACKGROUND: Altered immune responses are seen in depression, and recent data suggest that similar changes could also be observable in alexithymia. We examined whether the inflammatory markers high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 are independently related to alexithymia or its factors in a population-based sample.
METHODS: This study formed a clinical part of the Kuopio Depression (KUDEP) general population study focusing on the mental health of a general population of adults aged 25-64 years (n = 308). Alexithymia was measured using the Toronto Alexithymia Scale (TAS-20), and depressive symptoms were assessed using the Beck Depression Inventory (BDI-21).
RESULTS: The levels of IL-6 (in picograms per milliliter) and hs-CRP (in milligrams per liter) were significantly higher in alexithymic than in nonalexithymic subjects (IL-6 effect size, ES: 0.50; hs-CRP ES: 0.27). The BDI scores, hs-CRP and IL-6 explained 33.5% of the variation in TAS scores in the whole study population. According to logistic regression analysis, hs-CRP but not IL-6 increased the likelihood of belonging to the alexithymic group. This observation remained unaltered after additional adjustments for chronic inflammation-related disorders, the use of inflammation-modulating medications and depressive symptoms.
CONCLUSIONS: Our findings suggest that the association between hs-CRP and alexithymia resembles that observed in depressed patients. It is, however, independent of depressive symptoms. These findings widen our view on the stress-alexithymia concept.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21829048     DOI: 10.1159/000327583

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  15 in total

1.  Emotion suppression and mortality risk over a 12-year follow-up.

Authors:  Benjamin P Chapman; Kevin Fiscella; Ichiro Kawachi; Paul Duberstein; Peter Muennig
Journal:  J Psychosom Res       Date:  2013-08-06       Impact factor: 3.006

2.  Personality and the risk of cancer: a 16-year follow-up study of the GAZEL cohort.

Authors:  Cédric Lemogne; Silla M Consoli; Béatrice Geoffroy-Perez; Mireille Coeuret-Pellicer; Hermann Nabi; Maria Melchior; Frédéric Limosin; Marie Zins; Pierre Ducimetière; Marcel Goldberg; Sylvaine Cordier
Journal:  Psychosom Med       Date:  2013-03-19       Impact factor: 4.312

3.  Biological and other health related correlates of long-term life dissatisfaction burden.

Authors:  Teemu Rissanen; Soili M Lehto; Jukka Hintikka; Kirsi Honkalampi; Tarja Saharinen; Heimo Viinamäki; Heli Koivumaa-Honkanen
Journal:  BMC Psychiatry       Date:  2013-08-01       Impact factor: 3.630

4.  Nothing to smile about.

Authors:  Maria Luca; Antonina Luca; Carmelo Maria Augusto Vittorio Grasso; Carmela Calandra
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-23       Impact factor: 2.570

5.  Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

Authors:  Danilo Carrozzino; Piero Porcelli
Journal:  Front Psychol       Date:  2018-04-06

6.  High levels of alexithymia in patients with multiple sclerosis.

Authors:  Audred Cristina Biondo Eboni; Mariana Cardoso; Felipe Moreira Dias; Paulo Diniz da Gama; Sidney Gomes; Marcus Vinicius Magno Goncalves; Suzana Costa Nunes Machado; Adaucto Wanderley da Nobrega; Monica Fiuza Konke Parolin; Sonia Castedo Paz; Heloisa Helena Ruocco; Claudio Scorcine; Fabio Siquineli; Caroline Vieira Spessotto; Carlos Bernardo Tauil; Yara Dadalti Fragoso
Journal:  Dement Neuropsychol       Date:  2018 Apr-Jun

7.  Alexithymic Traits and Hair Cortisol Concentrations in Pregnant Women.

Authors:  Jani Kajanoja; Max Karukivi; Paula Mustonen; Noora M Scheinin; Susanna Kortesluoma; Ana João Rodrigues; Hasse Karlsson; Linnea Karlsson
Journal:  Front Psychiatry       Date:  2020-05-13       Impact factor: 4.157

Review 8.  Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review.

Authors:  Domenico De Berardis; Michele Fornaro; Laura Orsolini; Alessandro Valchera; Alessandro Carano; Federica Vellante; Giampaolo Perna; Gianluca Serafini; Xenia Gonda; Maurizio Pompili; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

9.  Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study.

Authors:  Francesco Vadini; Federica Sozio; Giordano Madeddu; Giuseppe De Socio; Paolo Maggi; Giuseppe Nunnari; Francesca Vichi; Paola Di Stefano; Elisa Tracanna; Ennio Polilli; Antonina Sciacca; Bernardetta Zizi; Vincenzo Lai; Claudio Bartolozzi; Maria Elena Flacco; Paolo Bonfanti; Francesca Santilli; Lamberto Manzoli; Giustino Parruti
Journal:  Open Forum Infect Dis       Date:  2019-07-27       Impact factor: 3.835

10.  Alexithymia and metabolic syndrome: the mediating role of binge eating.

Authors:  Chiara Conti; Giulia Di Francesco; Melania Severo; Roberta Lanzara; Katie Richards; Maria Teresa Guagnano; Piero Porcelli
Journal:  Eat Weight Disord       Date:  2020-09-13       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.